2,702 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

A179720

LendingMachine
₩10,200.00-21.5%229.0%₩21.0bn/an/an/an/aSoftware

A233990

Ha U Dong Chun
₩423.00-14.0%-29.3%₩5.9bn/an/an/an/aHousehold

A112190

KC IndustryLtd
₩1,589.00-0.3%-33.5%₩11.3bn/an/an/an/aMaterials

A311960

AItheNutrigene
₩12,100.00-1.6%-19.3%₩37.1bn/an/an/an/aPharmaceuticals & Biotech

A238170

NSM
₩415.000.2%-9.8%₩8.6bn/an/an/an/aMaterials

A379390

Ihsung Cni
₩8,400.000%-14.3%₩23.9bn/an/an/an/aCapital Goods

A260870

SK Signet
₩20,900.00-7.5%-66.0%₩128.1bn/an/an/an/aCapital Goods

A457630

Daishin Balance No.16 Special Purpose Acquisition
₩2,620.000%n/a₩19.2bn/an/an/an/aDiversified Financials

A212310

Organ Eco TechLtd
₩2,465.00-12.0%2.3%₩25.1bn/an/an/an/aHealthcare

A266470

BioInfra Life Science
₩270.00-22.6%-51.8%₩3.8bn/an/an/an/aPharmaceuticals & Biotech

A236340

MEDIZEN HUMANCARE
₩5,400.004.0%-8.8%₩12.4bn/an/an/an/aPharmaceuticals & Biotech

A200580

MEDYSSEYLtd
₩10,890.00-1.6%-19.3%₩37.9bn/an/an/an/aHealthcare

A216400

Invites Biocore
₩8,980.00-2.1%-0.1%₩69.2bn/an/an/an/aPharmaceuticals & Biotech

A066830

Genotech
₩1,590.00-0.4%-41.0%₩8.9bn/an/an/an/aPharmaceuticals & Biotech

A251280

Angiolab
₩3,845.002.5%-51.9%₩11.5bn/an/an/an/aPharmaceuticals & Biotech

A052960

Tae Yang 3C
₩3,995.00-2.4%-9.9%₩19.5bn/an/an/an/aSemiconductors

A180060

Topsun
₩11,810.000.6%26.7%₩95.7bn/an/an/a0%Semiconductors

A224760

NSCompany
₩4,650.00-13.4%-7.0%₩18.3bn/an/an/an/aCapital Goods

A322190

Verne
₩99.000%-8.3%₩743.0mn/an/an/an/aAutomobiles

A215570

Cronex
₩688.005.0%-60.4%₩2.2bn/an/an/an/aPharmaceuticals & Biotech

A446600

KAI Biotech
₩6,340.000%n/a₩6.2bn/an/an/an/aPharmaceuticals & Biotech

A419540

Bistos
₩2,070.00-3.3%-21.0%₩47.6bn/an/an/an/aHealthcare

A234920

Zaigle
₩7,510.00-4.2%-69.3%₩100.8bn/an/an/an/aConsumer Durables

A446750

Hana 26 Special Purpose Acquisition
₩2,200.000.5%9.2%₩13.3bn/an/an/an/aDiversified Financials
Page 99 of 113
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.